SOHO State of the Art Updates and Next Questions || Chronic Myeloid Leukemia and Pregnancy: “Per Aspera Ad Astra”
Chronic myeloid leukemia (CML) has evolved from an invariably fatal disease to a chronic disorder that can be treated with targeted drugs and allows survival expectations approaching age-matched controls. Thus, pregnancy and conception in CML should not be precluded anymore; however, to ensure the well-being of both the mother and the developing fetus careful planning and management are required. Tyrosine Kinase Inhibitors (TKIs) are not genotoxic or carcinogenic but can pose a risk to the developing fetus, due to their teratogenic potential.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Simona Bernardi Tags: Review Article Source Type: research
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia | Lymphoma | Myeloma | Pregnancy